HNF1A
Hepatocyte nuclear factor 1-alpha
Also known as: HNF1A_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- P20823
- Gene
- HNF1A
- Canonical length
- 631 aa
- Protein class
- Cancer-related genes, Human disease related genes, Predicted intracellular proteins
OverviewNCBI Gene
No narrative summary is available for HNF1A in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
631 residues, UniProt reviewed canonical sequence.
>P20823|HNF1A
1 MVSKLSQLQT ELLAALLESG LSKEALIQAL GEPGPYLLAG EGPLDKGESC GGGRGELAEL
61 PNGLGETRGS EDETDDDGED FTPPILKELE NLSPEEAAHQ KAVVETLLQE DPWRVAKMVK
121 SYLQQHNIPQ REVVDTTGLN QSHLSQHLNK GTPMKTQKRA ALYTWYVRKQ REVAQQFTHA
181 GQGGLIEEPT GDELPTKKGR RNRFKWGPAS QQILFQAYER QKNPSKEERE TLVEECNRAE
241 CIQRGVSPSQ AQGLGSNLVT EVRVYNWFAN RRKEEAFRHK LAMDTYSGPP PGPGPGPALP
301 AHSSPGLPPP ALSPSKVHGV RYGQPATSET AEVPSSSGGP LVTVSTPLHQ VSPTGLEPSH
361 SLLSTEAKLV SAAGGPLPPV STLTALHSLE QTSPGLNQQP QNLIMASLPG VMTIGPGEPA
421 SLGPTFTNTG ASTLVIGLAS TQAQSVPVIN SMGSSLTTLQ PVQFSQPLHP SYQQPLMPPV
481 QSHVTQSPFM ATMAQLQSPH ALYSHKPEVA QYTHTGLLPQ TMLITDTTNL SALASLTPTK
541 QVFTSDTEAS SESGLHTPAS QATTLHVPSQ DPASIQHLQP AHRLSASPTV SSSSLVLYQS
601 SDSSNGQSHL LPSNHSVIET FISTQMASSS QLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HNF1A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.6
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- duodenum: 13 nTPM
- small intestine: 13 nTPM
- liver: 9.7 nTPM
- kidney: 8.1 nTPM
- pancreas: 5.1 nTPM
- stomach: 3.6 nTPM
Single-cell type
- proximal tubule cells: 66 nCPM
- enterocytes: 37 nCPM
- oocytes: 32 nCPM
- hepatocytes: 26 nCPM
- colonocytes: 15 nCPM
- enteric transient amplifying cells: 14 nCPM
Immune cell
- basophil: 0.3 nTPM
- neutrophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- white matter: 0.7 nTPM
- medulla oblongata: 0.6 nTPM
- pons: 0.6 nTPM
- cerebellum: 0.5 nTPM
- cerebral cortex: 0.5 nTPM
- hypothalamus: 0.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about HNF1A.
Disease | AllUniProt
Conditions HNF1A is implicated in, by any mechanism.
- Hepatic adenomas familial (HEPAF) MIM:142330
- Maturity-onset diabetes of the young 3 (MODY3) MIM:600496
- Type 1 diabetes mellitus 20 (T1D20) MIM:612520
Disease | GeneticClinVar
393 pathogenic / likely-pathogenic of 1,227 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Monogenic diabetes
- Maturity-onset diabetes of the young
- Maturity-onset diabetes of the young type 3
- HNF1A-related disorder
- 6 conditions
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.33
- gnomAD pLI
- 0.96
- gnomAD missense Z
- 1.14
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- D-glucose import
- glucose homeostasis
- insulin secretion
- liver development
- pancreas development
- positive regulation of DNA-templated transcription
- positive regulation of transcription by RNA polymerase II
- positive regulation of transcription initiation by RNA polymerase II
- regulation of transcription by RNA polymerase II
- renal D-glucose absorption
Molecular functions
- DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- protein dimerization activity
- protein heterodimerization activity
- protein homodimerization activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- transcription cis-regulatory region binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Homeodomain
- Hepatocyte nuclear factor 1, beta isoform, C-terminal
- Hepatocyte nuclear factor 1, N-terminal
- Homedomain-like superfamily
- Lambda repressor-like, DNA-binding domain superfamily
- Hepatocyte nuclear factor 1, N-terminal domain superfamily
- Hepatocyte nuclear factor 1
- HNF-1, dimerization domain
- HNF-1, POU-specific (POUs) atypical domain
- Hepatocyte nuclear factor 1 (HNF-1), beta isoform C terminus
- Hepatocyte nuclear factor 1 (HNF-1), N terminus
- Hepatocyte nuclear factor 1, alpha isoform C-terminal
- Hepatocyte nuclear factor 1 (HNF-1), alpha isoform C terminus
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HNF1A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HNF1A as an antibody target. Whether an autoantibody or antibody against HNF1A could matter depends on whether native HNF1A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HNF1A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HNF1A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...